| Benevolence Hospice, Inc 14547 Titus St, Suite 204, Panorama City, CA, 91402 | |
| (818) 394-8588 |
News Archive
A pooled analysis of the global RESOLUTE clinical program presented today during a late-breaking clinical trials session at EuroPCR demonstrated the strong safety record of the Resolute drug-eluting stent (DES) from Medtronic, Inc., across a wide variety of patient and lesion types.
The microscopic structure of bone appears to predict which patients will experience poor outcomes after spinal fusion, according to a new study by researchers at Hospital for Special Surgery (HSS) in New York City.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Mariam Claeson, deputy director of maternal, newborn, and child health at the foundation; France Donnay, senior program officer for maternal, neonatal and child health at the foundation; and Melanie Walker, deputy director of global development special initiatives at the foundation, reflect on the Global Maternal Health Conference 2013, which took place recently in Arusha, Tanzania.
In a British Journal of Clinical Pharmacology study of 259 older adults discharged from a general medical hospital, more than 4 in 5 patients were issued a potentially inappropriate prescription containing at least 1 potentially inappropriate medication or potential prescribing omission.
› Verified 9 days ago
| Name | Benevolence Hospice, Inc |
|---|---|
| Location | 14547 Titus St, Suite 204, Panorama City, California |
| Hospice ID | 921529 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | The Joint Commission (TJC) |
| SSA county code | 200 |
News Archive
A pooled analysis of the global RESOLUTE clinical program presented today during a late-breaking clinical trials session at EuroPCR demonstrated the strong safety record of the Resolute drug-eluting stent (DES) from Medtronic, Inc., across a wide variety of patient and lesion types.
The microscopic structure of bone appears to predict which patients will experience poor outcomes after spinal fusion, according to a new study by researchers at Hospital for Special Surgery (HSS) in New York City.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Mariam Claeson, deputy director of maternal, newborn, and child health at the foundation; France Donnay, senior program officer for maternal, neonatal and child health at the foundation; and Melanie Walker, deputy director of global development special initiatives at the foundation, reflect on the Global Maternal Health Conference 2013, which took place recently in Arusha, Tanzania.
In a British Journal of Clinical Pharmacology study of 259 older adults discharged from a general medical hospital, more than 4 in 5 patients were issued a potentially inappropriate prescription containing at least 1 potentially inappropriate medication or potential prescribing omission.
› Verified 9 days ago
| NPI Number | 1194084525 |
| Organization Name | Benevolence Hospice, Inc. |
| Address | 14547 Titus St Panorama City, California, 91402 |
| Phone Number | (818)394-8588 |
News Archive
A pooled analysis of the global RESOLUTE clinical program presented today during a late-breaking clinical trials session at EuroPCR demonstrated the strong safety record of the Resolute drug-eluting stent (DES) from Medtronic, Inc., across a wide variety of patient and lesion types.
The microscopic structure of bone appears to predict which patients will experience poor outcomes after spinal fusion, according to a new study by researchers at Hospital for Special Surgery (HSS) in New York City.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Mariam Claeson, deputy director of maternal, newborn, and child health at the foundation; France Donnay, senior program officer for maternal, neonatal and child health at the foundation; and Melanie Walker, deputy director of global development special initiatives at the foundation, reflect on the Global Maternal Health Conference 2013, which took place recently in Arusha, Tanzania.
In a British Journal of Clinical Pharmacology study of 259 older adults discharged from a general medical hospital, more than 4 in 5 patients were issued a potentially inappropriate prescription containing at least 1 potentially inappropriate medication or potential prescribing omission.
› Verified 9 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
A pooled analysis of the global RESOLUTE clinical program presented today during a late-breaking clinical trials session at EuroPCR demonstrated the strong safety record of the Resolute drug-eluting stent (DES) from Medtronic, Inc., across a wide variety of patient and lesion types.
The microscopic structure of bone appears to predict which patients will experience poor outcomes after spinal fusion, according to a new study by researchers at Hospital for Special Surgery (HSS) in New York City.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Mariam Claeson, deputy director of maternal, newborn, and child health at the foundation; France Donnay, senior program officer for maternal, neonatal and child health at the foundation; and Melanie Walker, deputy director of global development special initiatives at the foundation, reflect on the Global Maternal Health Conference 2013, which took place recently in Arusha, Tanzania.
In a British Journal of Clinical Pharmacology study of 259 older adults discharged from a general medical hospital, more than 4 in 5 patients were issued a potentially inappropriate prescription containing at least 1 potentially inappropriate medication or potential prescribing omission.
› Verified 9 days ago
| Home Health Aides | 0.2 |
| Counselors | 1 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 1 |
| Physicians | 0.1 |
| Registered Nurses | 1 |
| Other Personnel | 1 |
| Total Employees | 5.3 |
|---|
News Archive
A pooled analysis of the global RESOLUTE clinical program presented today during a late-breaking clinical trials session at EuroPCR demonstrated the strong safety record of the Resolute drug-eluting stent (DES) from Medtronic, Inc., across a wide variety of patient and lesion types.
The microscopic structure of bone appears to predict which patients will experience poor outcomes after spinal fusion, according to a new study by researchers at Hospital for Special Surgery (HSS) in New York City.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Mariam Claeson, deputy director of maternal, newborn, and child health at the foundation; France Donnay, senior program officer for maternal, neonatal and child health at the foundation; and Melanie Walker, deputy director of global development special initiatives at the foundation, reflect on the Global Maternal Health Conference 2013, which took place recently in Arusha, Tanzania.
In a British Journal of Clinical Pharmacology study of 259 older adults discharged from a general medical hospital, more than 4 in 5 patients were issued a potentially inappropriate prescription containing at least 1 potentially inappropriate medication or potential prescribing omission.
› Verified 9 days ago
| Others | 0.5 |
| Total Volunteers | 0.5 |
|---|
News Archive
A pooled analysis of the global RESOLUTE clinical program presented today during a late-breaking clinical trials session at EuroPCR demonstrated the strong safety record of the Resolute drug-eluting stent (DES) from Medtronic, Inc., across a wide variety of patient and lesion types.
The microscopic structure of bone appears to predict which patients will experience poor outcomes after spinal fusion, according to a new study by researchers at Hospital for Special Surgery (HSS) in New York City.
In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Mariam Claeson, deputy director of maternal, newborn, and child health at the foundation; France Donnay, senior program officer for maternal, neonatal and child health at the foundation; and Melanie Walker, deputy director of global development special initiatives at the foundation, reflect on the Global Maternal Health Conference 2013, which took place recently in Arusha, Tanzania.
In a British Journal of Clinical Pharmacology study of 259 older adults discharged from a general medical hospital, more than 4 in 5 patients were issued a potentially inappropriate prescription containing at least 1 potentially inappropriate medication or potential prescribing omission.
› Verified 9 days ago
| Holistic Hospice, Inc. Location: 9608 Van Nuys Blvd,, Suite 203, Panorama City, California, 91402 Phone: (818) 394-8588 |
| Angelino Hospice Care, Inc Location: 14621 Titus Street, Suite 128, Panorama City, California, 91402 Phone: (818) 394-8588 |
| Loyal Hospice Care, Inc Location: 9608 Van Nuys Blvd, Suite 207-b, Panorama City, California, 91402 Phone: (818) 394-8588 |
| Aleve Hospice Care Of Los Angeles, Inc Location: 9608 Van Nuys Blvd, Suite 105, Panorama City, California, 91402 Phone: (818) 394-8588 |